High-precision minimally invasive surgery performed with the Da Vinci X and Xi robotic systems. Prof. Violante Di Donato is TR-400 Console Surgeon certified — one of the most advanced qualifications available in robotic gynecologic surgery — with specific expertise in oncologic staging, radical procedures, deep infiltrating endometriosis, and surgery in patients with obesity or major comorbidities.
TR-400 Console Surgeon CertifiedDa Vinci X & Xi SystemsIRCAD Strasbourg Training
🖼️
[Image placeholder — Da Vinci console / OR photo]
Suggested: davinci-xi-console.jpg (already in /visione/galleria/robotica/)
1 · What It Is
The Da Vinci Robotic Platform
The Da Vinci Surgical System is the most widely adopted robotic platform in gynecologic surgery worldwide. It enables the surgeon to operate through very small abdominal incisions (typically 8 mm), using articulated instruments that reproduce and enhance the natural movements of the human hand, with a level of precision and control not achievable with conventional laparoscopy.
Three technical features define the Da Vinci approach:
High-definition 3D vision with enhanced magnification — the operative field is seen with true binocular depth perception, at up to 10× magnification, offering anatomical detail unavailable with standard laparoscopy or open surgery.
EndoWrist instruments with 7 degrees of freedom — the instruments can rotate and flex beyond the capabilities of the human wrist, allowing extremely precise dissection in narrow anatomical spaces.
Elimination of physiological tremor and consistent image stability — the robotic interface filters out natural hand tremor and maintains a stable field of view, reducing surgeon fatigue during long, complex procedures.
Compared to conventional laparoscopy, the robotic approach offers superior dexterity in deep anatomical dissections, reduces surgeon fatigue in complex cases, and facilitates the execution of technically demanding procedures such as radical pelvic surgery, deep endometriosis resection, and complex reconstructive work.
2 · Indications
When Robotic Surgery Is Indicated
Prof. Di Donato performs robotic gynecologic surgery across three main clinical areas, following a rigorous case-selection framework aligned with international guidelines (ESGO 2024–25, ACOG, SIGO).
Gynecologic Oncology — The Core
Endometrial carcinoma — robotic staging surgery is the approach of choice, integrating sentinel lymph node (SLN) biopsy for precise pelvic and para-aortic mapping. The robotic platform facilitates both early-stage and locally advanced disease management.
Cervical carcinoma — selected early-stage cases following the post-LACC Trial protocol. Querleu-Morrow type B/C radical hysterectomy with nerve-sparing technique to preserve bladder and sexual function.
Oncologic staging — systematic retroperitoneal approach, SLN-guided selective lymphadenectomy, full pelvic and para-aortic staging where indicated.
Complex Reconstructive & Benign Surgery
Deep infiltrating endometriosis — compartmental surgical management of posterior and ureteral segments, with nerve-sparing technique for rectovaginal, vesical and ureteric nodules.
Urogynecology — suspension of endopelvic fasciae and ligaments using robotic technique for multi-compartment prolapse repair (sacrocolpopexy, paravaginal repair).
Contained robotic myomectomy — selected cases with multi-layer uterine reconstruction and in-bag protected specimen extraction to respect oncologic safety.
Hysterectomy for complex pathology — distorted anatomy, severe adhesions, very large uterine volumes, previous multiple surgeries.
Surgery in Fragile Patients
Severe obesity (BMI ≥ 30) — robotic surgery dramatically reduces the laparotomic conversion rate, abdominal-wall complications, and recovery times compared to both laparoscopy and open surgery in this population.
Patients with cardiovascular or respiratory comorbidities — the lower physiological impact of controlled pneumoperitoneum and steep Trendelenburg can be optimized by the robotic approach, minimizing surgical stress.
3 · How It Works
The Procedure — Step by Step
A typical robotic gynecologic procedure follows a structured sequence, from patient preparation to recovery. The exact duration depends on the specific pathology, but most interventions are completed in a single operating session.
01
Anesthesia & Positioning
General anesthesia with endotracheal intubation. The patient is placed in modified lithotomy position with steep Trendelenburg to allow pelvic exposure.
02
Port Placement
4–5 small incisions (8 mm for robotic ports, 12 mm for the assistant port) are placed in a specific configuration on the abdomen. Pneumoperitoneum is established.
03
Docking
The Da Vinci robotic arms are connected ("docked") to the ports. The surgeon operates from the console; the bedside assistant changes instruments and manages the operative field.
04
Surgical Procedure
The procedure is performed with 3D HD vision and articulated EndoWrist instruments. Dissection, hemostasis, resection and reconstruction follow the pre-planned surgical strategy.
05
Specimen Extraction
The surgical specimen is extracted — transvaginally, through a minilaparotomy, or in a protective bag (in-bag extraction) depending on the case and oncologic considerations.
06
Closure & Recovery
Ports are closed with absorbable sutures. Most patients are mobilized within a few hours and can often be discharged within 1–2 days depending on the procedure.
4 · Advantages
Evidence-Based Advantages
The benefits of robotic gynecologic surgery, compared to both open surgery and conventional laparoscopy, are supported by a substantial body of evidence across multiple gynecologic indications.
Reduced Blood Loss
Meta-analyses consistently show lower intraoperative blood loss and transfusion rates compared to open surgery, with rates comparable to or better than conventional laparoscopy.
Lower Conversion Rate
Especially relevant in obese patients and complex cases, where the conversion-to-laparotomy rate is significantly lower than with conventional laparoscopy.
Shorter Hospital Stay
Median hospital stay typically 1–2 days for most procedures, compared to 4–7 days after open surgery. Faster return to daily activities.
Less Postoperative Pain
Reduced need for opioid analgesia, smaller incisions, and lower abdominal-wall trauma contribute to significantly less postoperative pain.
Better Cosmetic Result
Four to five 8–12 mm incisions, often hidden below the bikini line, heal with minimal visible scarring.
Precision in Complex Anatomy
Superior dexterity enables more complete dissection in narrow spaces — crucial for radical hysterectomy, deep endometriosis, and nerve-sparing procedures.
5 · Patient Selection
Who Is a Candidate
Not every gynecologic condition is best treated with the robotic approach. The choice among robotic surgery, conventional laparoscopy, vaginal surgery, and mini-laparotomy is made on a case-by-case basis, considering oncologic safety first, then patient characteristics and technical feasibility.
Typical candidates for robotic gynecologic surgery include:
Women with early-stage endometrial cancer requiring full surgical staging with SLN mapping
Patients with early-stage cervical cancer selected per post-LACC Trial criteria
Women with deep infiltrating endometriosis involving the rectum, bladder or ureters
Patients with BMI ≥ 30 who require hysterectomy or complex pelvic surgery
Women with previous multiple laparotomies and expected severe adhesions
Patients with large uterine volumes requiring complex reconstruction
Women needing multi-compartment pelvic-floor reconstructive surgery
Robotic surgery may not be the first choice when: the oncologic profile of the disease requires an open approach for safety reasons, the patient has contraindications to prolonged steep Trendelenburg positioning, or when a vaginal or mini-laparotomic approach offers equivalent results with less operative complexity.
A note on oncologic safety. The choice of surgical technique is never driven by technology but by disease biology. Every indication is evaluated according to the most recent international standards — ACOG, SIGO, ESGO 2024–25 — to ensure that robotic innovation always serves maximum oncologic safety, not the other way around.
6 · Recovery
Recovery & Outcomes
Postoperative recovery after robotic gynecologic surgery is typically faster than after open surgery, and comparable to or better than conventional laparoscopy. Specific timelines depend on the procedure performed (simple hysterectomy vs radical hysterectomy with lymphadenectomy vs deep endometriosis surgery), but general patterns apply.
D0
Day of Surgery
Transfer to ward within a few hours. Liquid diet typically restarted the same evening. Early mobilization (within 4–6 hours) is encouraged to reduce thromboembolic risk.
D1–2
Early Discharge
Most patients are discharged within 24–48 hours for simple procedures, 2–3 days for more complex ones. Solid diet resumed, independent walking, oral analgesia only.
W1–2
First Two Weeks
Return to light daily activities. Avoid heavy lifting (> 5 kg) and vigorous exercise. Wound care as instructed. First follow-up visit typically scheduled around day 10–14.
W4–6
Full Recovery
Gradual return to full physical activity including driving and exercise. Return to sexual activity and resumption of work depend on the specific procedure and are discussed individually.
7 · Research & Evidence
The Evidence Base
The adoption of robotic surgery in gynecology is supported by an extensive body of clinical evidence. Below are the key trials and studies that have shaped current practice — and that inform Prof. Di Donato's clinical decision-making.
LACC Trial (NEJM 2018)
The Laparoscopic Approach to Cervical Cancer trial reshaped global practice in cervical cancer surgery, showing inferior oncologic outcomes with minimally invasive radical hysterectomy in unselected populations. Subsequent real-world evidence has identified specific subgroups (small tumors < 2 cm, no deep stromal invasion) where minimally invasive approaches remain safe. This drives the rigorous case-selection protocol used at our center.
PORTEC Studies & RAINBO Platform
The PORTEC-3 and PORTEC-4a trials, together with the RAINBO platform, have established the role of molecular classification (POLE, MMR, p53, NSMP) in endometrial cancer, enabling precision adjuvant therapy. Robotic surgical staging with SLN biopsy integrates seamlessly with this molecular stratification, reducing morbidity while maintaining oncologic precision.
SENTOR / FIRES / SENTI-ENDO
These studies validated sentinel lymph node biopsy in endometrial cancer as a safe alternative to systematic lymphadenectomy, significantly reducing surgical morbidity without compromising oncologic outcomes. Robotic surgery facilitates precise SLN mapping and pelvic/para-aortic staging.
SUCCOR Study
Retrospective European study investigating outcomes of radical hysterectomy for cervical cancer by surgical approach, contributing to refinement of patient selection criteria post-LACC. Informs our approach to early-stage cervical cancer where minimally invasive surgery remains appropriate.
Cochrane & Meta-Analyses on Benign Gynecologic Surgery
Multiple meta-analyses have compared robotic, laparoscopic and open approaches for benign hysterectomy and myomectomy. Findings consistently show lower conversion rates in obese patients and complex cases, with comparable oncologic and functional outcomes.
Prof. Di Donato's own research contribution: author of over 266 peer-reviewed publications indexed on Scopus, with active research in gynecologic oncology surgery, molecular classification of endometrial cancer, robotic surgery outcomes, and surgical de-escalation. View full publication list →
8 · Frequently Asked Questions
FAQ — Robotic Gynecologic Surgery
Is robotic surgery "better" than laparoscopic surgery?
Not universally — and this is a critical point. For many standard gynecologic procedures, conventional laparoscopy achieves excellent outcomes with lower costs. Robotic surgery offers clear advantages in specific clinical scenarios: very complex anatomical dissections, severe obesity, nerve-sparing radical procedures, and deep endometriosis. The choice is made on clinical grounds, not on technology preference.
Will I have visible scars?
Typically four to five small incisions of 8–12 mm are placed on the abdomen. Scars are usually barely visible once healed, especially when ports are positioned below the bikini line. A slightly larger incision may be needed to extract the surgical specimen, but even this is much smaller than an open-surgery scar.
How long does the surgery last?
The duration varies substantially by procedure: a simple robotic hysterectomy may take 90–120 minutes, a radical hysterectomy with lymphadenectomy 3–4 hours, and complex deep endometriosis surgery 4–6 hours. Prof. Di Donato provides a detailed time estimate during the preoperative consultation.
When can I go home after robotic surgery?
Most patients are discharged 24–48 hours after surgery for standard procedures. More complex interventions (radical hysterectomy, extensive endometriosis surgery) may require 2–4 days of hospitalization. International patients are typically advised to remain in Rome for 7–10 days after surgery to allow first follow-up and imaging before returning home.
I'm traveling from abroad for surgery. How does it work?
Prof. Di Donato regularly treats international patients. The typical pathway involves: (1) remote review of your records and imaging (Second Opinion); (2) in-person consultation in Rome with pre-operative assessment; (3) surgery at an accredited Rome facility; (4) hospital stay; (5) postoperative recovery period in Rome before return travel; (6) long-distance follow-up coordination. English-speaking support is available throughout.
Discuss Your Case with Prof. Di Donato
Request a personalized consultation or submit your records for a Second Opinion review. International patients are welcome.